MoneyWorks4Me

JB Chemicals & Pharmaceuticals enters Nephrology segment in India

06 May 2021 Evaluate

JB Chemicals & Pharmaceuticals (JBCPL) has forayed into the area of Nephrology with a new dedicated division called ‘RENOVA’ which will endeavour to serve patients who are under treatment for Chronic Kidney Disease.

The new division will focus exclusively on comprehensive renal care ranging from the management of hypertension in Chronic Kidney Disease to End-stage renal disease. After successfully becoming one of the leading player in Hypertension with brands like Cilacar and Nicardia, JBCPL has now begun to also focus on patients with CKD. 

JB Chemicals & Pharmaceuticals is engaged in manufacturing of pharmaceutical specialties in various dosage forms, herbal remedies, diagnostics, generic drugs, active pharmaceutical ingredients (APIs).

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..